Pancreatic cancer

Clinical Chemistry

Volumn 59, Issue 1, 2013, Pages 41-46

  Chrystoja, Caitlin C ^a   Diamandis, Eleftherios P ^a,b,c   Brand, Randall ^d   Rückert, Felix ^e   Haun, Randy ^f   Molina, Rafael ^g  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g Unit for Cancer Research   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA2 PROTEIN; CA 19-9 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; OXALIPLATIN; PROTEIN KINASE LKB1; TRASTUZUMAB; TRYPSIN; TRYPSIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS SURGERY; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS;

HUMANS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84872047429     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.196642     Document Type: Note

References (0)